Results 231 to 240 of about 556,334 (392)
This study presents an engineered probiotic platform, iRGD‐mRBC@FOLactis, combining red blood cell membrane cloaking and tumor‐penetrating peptide iRGD for enhanced PD‐1 blockade. The platform improves tumor targeting, immune cell activation and therapeutic efficacy in lung cancer, demonstrating significant promise in overcoming PD‐1/PD‐L1 therapy ...
Chen Chen+9 more
wiley +1 more source
Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules. [PDF]
Mary C. Wacholtz+2 more
openalex +1 more source
IL‐15‐engineered stem cell–NK cell complexes, assembled via bioorthogonal chemistry, enable effective lung cancer immunotherapy. Abstract Natural killer (NK) cells represent a powerful immunotherapeutic strategy due to their intrinsic cytotoxicity and ability to target tumor cells independently of antigen presentation.
Qian Zhang+15 more
wiley +1 more source
Adsorptive potential of hydrochar produced from avocado waste biomass for the sequestration of Alizarin red S dye from aquatic environment. [PDF]
Balji GB+4 more
europepmc +1 more source
GVHR elicited by products of class I or class II loci of the MHC: analysis of the response of mouse T lymphocytes to products of class I and class II loci of the MHC in correlation with GVHR-induced mortality, medullary aplasia, and enteropathy. [PDF]
P F Piguet
openalex +1 more source
Higher serum UA levels are associated with reduced AD risk in epidemiological studies. UA enhances microglial phagocytic capacity primarily by restoring CD36 and TREM2 receptor recycling that is impaired by Aβ exposure. Therapeutically, UA supplementation improves cognitive function and reduces neuropathology in AD mouse model by enhancing microglial ...
De Xie+18 more
wiley +1 more source
Principles and Framework for the Operationalisation of Meaningful Human Control Over Autonomous Systems. [PDF]
Calvert SC.
europepmc +1 more source
Xenopus MHC class II molecules. II. Polymorphism as determined by two-dimensional gel electrophoresis. [PDF]
Jim Kaufman+2 more
openalex +1 more source
CDK4/6 inhibition promotes CD8+ T cell expansion through tumor‐macrophage crosstalk by activating HIF‐1α and enhancing MIF‐CD44/CD74 signaling. This reprograms TAMs to boost MHC‐I antigen presentation, and CDK4/6 inhibitor‐trained M1 TAM supernatant therapy synergizes with low‐dose PD‐1 blockade to restore antitumor immunity.
Lin He+17 more
wiley +1 more source